AREVA Med Launches Production of Lead-212 at New Facility PARIS, Nov. 21, 2013 (GLOBE NEWSWIRE) -- AREVA Med inaugurated today the Maurice Tubiana Facility located at Bessines-sur-Gartempe, France (Limousin region). After receiving the administrative...

AREVA Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI BETHESDA, Md., May 17, 2013 (GLOBE NEWSWIRE) -- AREVA Med, an AREVA subsidiary specializing in the development of new innovative therapies to fight cancer, announced today that it will present...

Roche and AREVA Med Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy BASEL, Switzerland, PARIS and BETHESDA, Md., July 27, 2012 (GLOBE NEWSWIRE) -- Roche (SIX:RO; ROG) (OTCQX:RHHBY) and AREVA Med, a subsidiary of AREVA, announced today that they have entered into a...

AREVA Med's Clinical Trial Now Enrolling Patients at UAB Affiliates BETHESDA, Md., May 3, 2012 (GLOBE NEWSWIRE) -- AREVA Med announced that University of Alabama at Birmingham's (UAB) Cancer Center Network affiliates are now enrolling patients for the Phase I clinical...

AREVA Med Acquires Macrocyclics, Inc. BETHESDA, Md., Oct. 20, 2011 (GLOBE NEWSWIRE) -- AREVA announced today that its nuclear medicine subsidiary, AREVA Med, has acquired Macrocyclics, Inc. AREVA Med has developed innovative methods for...